SLC16A1 and B-cell non-Hodgkin lymphoma: In a study focusing on B-cell lymphoma by Lopez et al, the inhibition of MCT1 by AR-C155858, in conjunction with CAR-T cells, led to enhanced in vitro cytotoxicity and improved anti-tumor control in a mouse model.